Colorectal liver metastases. Neoadjuvant chemotherapy: Aspects of medical and surgical oncology;Kolorektale leberfiliae: Neoadjuvante chemotherapie aus internistischer und chirurgischer sicht

Internist

Volumn 48, Issue 1, 2007, Pages 51-58

  Reinacher Schick, Anke C ^a   Bechstein, W O ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Chemotherapy; Colorectal carcinoma; Liver metastases; Liver resection; Neoadjuvant therapy

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CETUXIMAB; FLUOROURACIL; IRINOTECAN; OXALIPLATIN;

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER SURGERY; COLORECTAL CANCER; DISEASE COURSE; FATTY LIVER; HUMAN; LIVER HISTOLOGY; LIVER METASTASIS; LIVER RESECTION; MORBIDITY; OBSTRUCTION; PROGNOSIS; RISK ASSESSMENT; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TUMOR DIAGNOSIS; VEIN EMBOLISM;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; EMBOLIZATION, THERAPEUTIC; FLUOROURACIL; HEPATECTOMY; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM STAGING; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33846590454     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-006-1770-0     Document Type: Article

References (41)

1. Abdalla EK, Vauthey JN, Ellis LM et al. (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239: 818-827
2. Adam R, Avisar E, Ariche A et al. (2001) Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal metastases. Ann Surg Oncol 8: 347-353
3. Adam R, Delvart V, Pascal G et al. (2004) Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240: 644-657
4. Adam R, Pascal G, Castaing D et al. (2004) Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 240: 1052-1061
5. Bechstein WO, Golling M (2005) Chirurgische Resektion kolorektaler Lebermetastasen. Was ist Standard? Chirurg 76: 543-551
6. Benoist S, Brouquet A, Penna C et al. (2006) Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 24: 3939-3945
7. Capussotti L, Muratore A, Mulas MM, Massucco P, Aglietta M (2006) Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases. Br J Surg 93: 1001-1006
8. Ellis LM, Curley SA, Grothey A (2005) Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab. J Clin Oncol 23: 4853-4855
9. Fernandez FG, Ritter J, Goodwin JW, Linehan DC, Hawkins WG, Strasberg SM (2005) Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on respectability of hepatic colorectal metastases. J Am Coll Surg 200: 845-853
10. Folprecht G, Grothey A, Alberts S, Raab HR, Kohne CH (2005) Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol 16: 1311-1399
11. Folprecht G, Lutz MP, Schoffski P et al. (2006) Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma. Ann Oncol 17: 450-456
12. Garden J, Rees M, Poston G et al. (2006) Guidelines for resection of colorectal cancer liver metastases. Gut 55: 1-8
13. Giacchetti S, Itzhaki M, Gruia G et al. (1999) Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 10: 663-669
14. Goldberg RM, Sargent DJ, Morton RF et al. (2004) A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22: 23-30
15. Grobmeyer SR, Wang L, Gonen M et al. (2006) Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy. Ann Surg 244: 260-264
16. Gruenberger T, Sorbye H, Debois M et al. (2006) Tumor response to pre-operative chemotherapy (CT) with FOLFOX-4 for resectable colorectal cancer liver metastases (LM) Interim results of EORTC Intergroup randomized phase III study 40983. J Clin Oncol, ASCO Annual Meeting Proceedings 24: 3500
17. Hamady ZZR, Cameron IC, Wyatt J, Prasad RK, Toogood GJ, Lodge JPA (2006) Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1 cm rule. Eur J Surg Oncol 32: 557-563
18. Hurwitz H, Fehrenbacher L, Novotny W et al. (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350: 2335-2342
19. Jaeck D, Oussoultzoglou E, Rosso E, Greget M, WeberJC, Bachellier P (2004) A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 240: 1037-1051
20. Lorenz M, Muller HH, Schramm H et al. (1998) Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen) Ann Surg 228: 756-762
21. Lorenz M, Staib-Sebler E, Gog C et al. (2003) Prospective pilot study of neoadjuvant chemotherapy with 5-fluorouracil, folinic acid and oxaliplatin in resectable liver metastases of colorectal cancer. Analysis of 42 neoadjuvant chemotherapies. Zentralbl Chir 128: 87-94
22. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM (2006) Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 244: 254-259
23. Masi G, Cupiini S, Marcucci L et al. (2006) Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer. Ann Surg Oncol 13: 58-65
24. Mentha G, Majno PE, Andres A, Rubbia-Brandt L, Morel P, Roth AD (2006) Neoadjuvant chemotherapy and resection of advance synchronous liver metastases before treatment of the colorectal primary. Br J Surg 93: 872-878
25. Meta-analysis Group In Cancer (1998) Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol 16: 301-308
26. Mitry E, Fields A, Bleiberg H et al. (2006) Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer. A meta-analysis of two randomized trials. J Clin Oncol, ASCO Annual Meeting Proceedings 24: 3524
27. Nordlinger B, Sorbye H, Debois M et al. (2005) Feasibility and risks of pre-operative chemotherapy (CT) with FOLFOX 4 and surgery for resectable colorectal cancer liver metastases (LM) Interim results of the EORTC Intergroup randomized phase III study 40983. J Clin Oncol, ASCO Annual Meeting Proceedings 23: 3528
28. Oussoultzoglu E, Bachellier P, Rosso E et al. (2006) Right portal vein embolization before right hepatectomy for unilobar colorectal liver metastases reduces the intrahepatic recurrence rate. Ann Surg 244: 71-79
29. Pawlik TM, Abdalla EK, Ellis LM, Vauthey JN, Curley SA (2006) Debunking dogma: Surgery for four or more colorectal liver metastases is justified. J Gastrointest Surg 10: 240-248
30. Poston GJ, Adam R, Alberts S et al. (2005) OncoSurge: A strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol 23: 7125-7134
31. Rubbia-Brandt L, Audard V, Sartoretti P et al. (2004) Oxaliplatin may induce severe hepatic sinusoidal obstruction (veno-occlusive lesion) in treatment of advanced colorectal cancer. Ann Oncol 15: 460-466
32. Selzner M, Hany TF, Wildbrett P, McCormack L, Kadry Z, Clavien PA (2004) Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer in the liver? Ann Surg 240: 1027-1036
33. Sperti E, Faggiuolo R, Gerbino A et al. (2006) Outcome of metastatic colroectal cancer: analysis of a consecutive series of 229 patients. The impact of a multidisciplinary approach. Dis Colon Rectum 49: 1596-1601
34. Titu LV, Breen DJ, Nicholson AA, Hartley J, Monson JRT (2006) Is routine magnetic resonance imaging justified for the early detection of respectable liver metastases from colorectal cancer? Dis Colon Rectum 49: 810-815
35. Tournigand C, Andre T, Achille E et al. (2004) FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 15: 229-237
36. Vauthey JN, Abdalla EK (2006) Unresectable hepatic colorectal metastases: need for new surgical strategies. Ann Surg Oncol 13: 5-6
37. Vauthey JN, Pawlik TM, Ribero D et al. (2006) Chemotherapy regimen predicts steatohepatitits and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24: 2065-2072
38. Wade TP, Virgo KS, Li MJ, Callander PW, Longo WE, Johnson FE (1996) Outcome after detection of metastatic carcinoma of the colon and rectum in a national hospital system. J Am Coll Surg 182: 353-361
39. Yan TD, Padang R, Xia H, Zhao J, Li J, Morris DL (2006) Management of involved or close resection margins in 120 patients with colorectal liver metastases: edge cryotherapy can achieve long-term survival. Am J Surg 191: 735-742
40. Yedibela S, Elad L, Wein A et al. (2005) Neoadjuvant chemotherapy does not increase postoperative complication rate after resection of colorectal liver metastases. Eur J Surg Oncol 31: 141-146
41. Zorzi D, Mullen JT, Abdalla EK et al. (2006) Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases. J Gastrointest Surg 10: 86-94